Taylor Lee Braunberger, MD | |
2830 N Washington St, Bismarck, ND 58503-1482 | |
(701) 323-5400 | |
Not Available |
Full Name | Taylor Lee Braunberger |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 2830 N Washington St, Bismarck, North Dakota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811359003 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 4301112111 (Michigan) | Secondary |
207N00000X | Dermatology | 20321 (North Dakota) | Primary |
Entity Name | Brookview Medical Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871965855 PECOS PAC ID: 9537420450 Enrollment ID: O20180309000532 |
News Archive
Every 30 seconds somebody in the world is amputated as a consequence of foot complication due to diabetes. A new study at Sahlgrenska Academy, University of Gothenburg, Sweden, confirmes that shoe inserts, podiatry, regular checkups and other simple interventions can reduce the number of amputations by more than 50%.
Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that energy metabolism within the heart, measured using a noninvasive magnetic resonance imaging test, is a significant predictor of clinical outcomes, independent of a patient's symptoms or the strength of the heart's ability to pump blood, known as the ejection fraction.
Researchers at Oregon State University have found a way to use magnetic "nanobeads" to help detect chemical and biological agents, with possible applications in everything from bioterrorism to medical diagnostics, environmental monitoring or even water and food safety.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Taylor Lee Braunberger, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Taylor Lee Braunberger, MD 2830 N Washington St, Bismarck, ND 58503-1482 Ph: (701) 323-5400 |
News Archive
Every 30 seconds somebody in the world is amputated as a consequence of foot complication due to diabetes. A new study at Sahlgrenska Academy, University of Gothenburg, Sweden, confirmes that shoe inserts, podiatry, regular checkups and other simple interventions can reduce the number of amputations by more than 50%.
Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that energy metabolism within the heart, measured using a noninvasive magnetic resonance imaging test, is a significant predictor of clinical outcomes, independent of a patient's symptoms or the strength of the heart's ability to pump blood, known as the ejection fraction.
Researchers at Oregon State University have found a way to use magnetic "nanobeads" to help detect chemical and biological agents, with possible applications in everything from bioterrorism to medical diagnostics, environmental monitoring or even water and food safety.
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company's lead compound, Plinabulin.
› Verified 6 days ago
Theresa A Borrowman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-712-4500 | |
David L Appert, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6400 Fax: 017-323-5677 | |
Dr. Joseph A Luger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-751-9500 Fax: 701-751-9508 | |
Dr. Joseph Mark Ebertz, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2700 State St, Bismarck, ND 58503 Phone: 701-712-4500 Fax: 701-712-4011 | |
Dr. William Eugene Cornatzer Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 225 N 7th St # 2, United Bank Bldg, Bismarck, ND 58501 Phone: 701-224-1273 Fax: 701-323-2929 | |
Nicole Marie Soto, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6400 | |
Imran Aslam, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2830 N Washington St, Bismarck, ND 58503 Phone: 701-323-6400 Fax: 701-323-5677 |